NCT03551587 is a NA clinical trial of Vibringe in Endodontic Inflammation, sponsored by Cairo University.

Who is sponsoring NCT03551587?

NCT03551587 is sponsored by Cairo University.

What drugs are being tested in NCT03551587?

Interventions in NCT03551587: Vibringe.

What condition does NCT03551587 study?

NCT03551587 studies Endodontic Inflammation.

Is NCT03551587 still recruiting?

NCT03551587 is currently completed. Last updated 2 August 2019.

Last reviewed 2019-08-02 · How we verify

NCT03551587

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison Between the Vibringe and the Conventional Needle

Completed NA Last updated 2 August 2019

What this trial tests

NA trial testing Vibringe in Endodontic Inflammation in 18 participants. Completed in 28 February 2019.

Timeline

28 November 2017

Primary endpoint
27 January 2019

28 February 2019

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	18
Start date	28 November 2017
Primary completion	27 January 2019
Estimated completion	28 February 2019
Sites	1 location across Egypt

Drugs / interventions tested

Vibringe

Conditions studied

Endodontic Inflammation — all drugs for Endodontic Inflammation →

Sponsor

Cairo University

Who can join

Adults 25 to 45, any sex, with Endodontic Inflammation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Vibringe is the first endodontic sonic irrigation system that enables delivery and activation of the irrigation solution in the root canal, in only one step. The activation of the disinfectant by acoustic streaming, enriches and completes the irrigation procedure and improves the success rate of endodontic treatments. It has been shown that this system significantly improves debridement. It also improves the disruption of the smear layer and biofilm by activating irrigation solutions. As there are no previous studies comparing the Vibringe system with other irrigation techniques under clinical settings, in this regard, the aim of this study is to evaluate whether irrigation with Vibringe provides more or less benefit in terms of postoperative pain when compared with the conventional needle technique.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03551587 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 2 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03551587.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing